|
Q2 FY2016
As of Oct 31, 2016
|
Q1 FY2016
As of Jul 31, 2016
|
Q3 FY2015
As of Jan 31, 2016
|
Q2 FY2015
As of Oct 31, 2015
|
Q1 FY2015
As of Jul 31, 2015
|
Q4 FY2014
As of Apr 30, 2015
|
Q3 FY2014
As of Jan 31, 2015
|
Q2 FY2014
As of Oct 31, 2014
|
Q1 FY2014
As of Jul 31, 2014
|
Q4 FY2013
As of Apr 30, 2014
|
Q2 FY2013
As of Oct 31, 2013
|
Q1 FY2013
As of Jul 31, 2013
|
Q4 FY2012
As of Apr 30, 2013
|
Q3 FY2012
As of Jan 31, 2013
|
Q2 FY2012
As of Oct 31, 2012
|
Q1 FY2012
As of Jul 31, 2012
|
Q4 FY2011
As of Apr 30, 2012
|
Q3 FY2011
As of Jan 31, 2012
|
Q2 FY2011
As of Oct 31, 2011
|
Q4 FY2010
As of Apr 30, 2011
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and Cash Equivalents | ||||||||||||||||||||
| TOTAL ASSETS | ||||||||||||||||||||
| Current Liabilities | ||||||||||||||||||||
| Accounts Payable and Accrued Liabilities | ||||||||||||||||||||
| Convertible Note Payable | ||||||||||||||||||||
| Converible Note Payable (Note 6) | ||||||||||||||||||||
| TOTAL CURRENT LIABILITIES | ||||||||||||||||||||
| COMMITMENTS (Note 4) | ||||||||||||||||||||
| Issued and outstanding: 44,000,000 common shares | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| (Deficit) accumulated during the development stage | ||||||||||||||||||||
| TOTAL STOCKHOLDERS' EQUITY | ||||||||||||||||||||
| Total Liabilities and Stockholder's Equity | ||||||||||||||||||||
Loading...
